Panera ties-up with delivery aggregators UberEats, GrubHub & DoorDash
Category: #business  By Mateen Dalal  Date: 2019-08-29
  • share
  • Twitter
  • Facebook
  • LinkedIn

Panera ties-up with delivery aggregators UberEats, GrubHub & DoorDash

Leading bread brand Panera Bread has reportedly struck up a partnership with three third-party delivery services – UberEats, GrubHub and DoorDash.

Aside from Panera’s own delivery service, customers will now be able to place lunch and dinner orders through the third-party services. Deliveries, however, will still be carried out by Panera’s own drivers.

Recent years have seen a significant surge in the delivery sector, augmented by the presence of third-party delivery services. According to Technomic, customers spent nearly $10.2 billion on delivery aggregators in 2018. A 2019 report by Toast’s Restaurant Success also observed that consumers show loyalty towards a particular delivery platform.

Panera evaluated several delivery platforms before launching its own delivery service in 2015, citing the reason to be its capability towards offering a better experience for customers as compared to third party services.

According to Panera’s Chief Growth & Strategy Officer, Dan Wegiel, this investment proved fruitful for the company, with delivery becoming the leading growth driver for Panera for the past several years, accounting for nearly 7% of overall sales.

Over the past 5 years, numerous aggregators have shown interest in having Panera become a part of their platforms.

However, Panera has certain terms on which they would agree to the tie-ups, including the complete integration of the platforms into Panera’s system, access to customer data from the third-party service among others, which the aggregators agreed to negotiate by late 2018.

To facilitate these terms, Panera plans to integrate its customer loyalty program into the delivery experience soon.

Panera will also modify its payment model for the drivers to ensure that they receive 100% of the tips, in light of one of its partners DoorDash recently being criticized for its tipping policies.

This partnership is expected to bring in adding more names to Panera’s customer base. Panera is also working on improving its accessibility to a wide range of customers and has also expanded its breakfast menu to include more options like wraps. Testing for a new dinner menu is also underway.

Terms of the deal are yet to be disclosed.

Source Credit: https://www.cnbc.com/2019/08/27/panera-partners-with-ubereats-doordash-grubhub-to-expand-delivery.html

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Lineage Cell Therapeutics’ Renevia bags CE Mark Approval for EU market
Lineage Cell Therapeutics’ Renevia bags CE Mark Approval for EU market
By Mateen Dalal

Aesthetic medicine is increasingly being used for the treatment of physical impairments such as skin discoloration, excessive fat, scars, skin laxity, wrinkles, cellulite, and liver spots. Customer are seen demanding for resurfacing and non-invasive ...

Cipla and PULM dose first patient with Pulmazole in Phase 2 ABPA trial
Cipla and PULM dose first patient with Pulmazole in Phase 2 ABPA trial
By Mateen Dalal

There is a substantial rise in the number of people affected with pulmonary diseases like asthma. Various pharmaceutical companies in the world are combining their capabilities to find treatments for serious pulmonary diseases to address the needs of...

AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620
AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620
By Mateen Dalal

As cases of neurodegenerative diseases like Alzheimer’s and Parkinson’s are on a rise, biopharmaceutical firms are actively engaging in developing new clinical drugs. Companies are also gaining increased funding from partners to further t...